Tecsys Announces Renewal of Its Normal Course Issuer Bid

Montreal, Canada. September 30, 2026 – Tecsys Inc. (“Tecsys” or the “Company”) (TSX:
TCS) today announced that the Toronto Stock Exchange (the “TSX”) has approved the
renewal of the Company’s normal course issuer bid (“NCIB”).

Tecsys believes that the market value of its common shares (“Shares”) may not always
fully reflect the full value of the Company and, in such circumstances, purchases under
the NCIB may represent an appropriate and desirable use of its available funds. Such
purchases will increase the proportional share interest of those shareholders who retain
their Shares. Any purchases made by Tecsys under the NCIB will be made by Tecsys at the
prevailing market price at the time of acquisition, plus brokerage fees, through the
facilities of the TSX and other designated exchanges and/or alternative Canadian trading
systems.

Pursuant to the NCIB, during the twelve-month period commencing October 2, 2026, and
ending October 1, 2027, Tecsys intends to purchase up to 900,000 Shares, which
represents 9.2% of the Company’s public float as of September 21, 2026. As of that date,
the Company had 14,416,937 shares issued and outstanding, of which 9,754,906 common
shares constituted the public float. Under the NCIB, other than purchases made under
block purchase exemptions, Tecsys may purchase up to 2,789 Shares on the TSX during
any trading day, which represents 25% of 11,157, being the average daily trading volume
for the six months ended August 31, 2026, excluding shares purchased under the NCIB
during that time. Any Shares purchased under the NCIB will be cancelled.

Share repurchases made pursuant to the Company’s NCIB will be predicated upon
maintaining a strong balance sheet, performance of the business, and the availability and
attractiveness of alternative capital investment opportunities. The actual number of
Shares purchased under the NCIB, the timing of the purchases, and the price at which the
Shares are acquired will depend upon a variety of factors including future market
conditions.

Tecsys has established an automatic securities purchase plan with a designated broker,
which will allow for the purchase for cancellation of Shares under the NCIB, subject to
certain trading parameters, by its designated broker during times when Tecsys would
ordinarily not be active in the market due to applicable regulatory restrictions or selfimposed blackout periods. Outside of these periods, the Shares will be repurchased by
Tecsys at its discretion under the NCIB.

Under its prior normal course issuer bid (“Prior NCIB”), which commenced on September
20, 2025, and ended September 19, 2026, the Company sought and received approval
from the TSX to purchase up to 900,000 common shares, as amended effective March 19,
2026. The Company purchased 388,400 common shares under the Prior NCIB at a
weighted average price of $30.20 per common share through the facilities of the TSX and
other designated exchanges and/or alternative Canadian trading systems.

About Tecsys

Tecsys is trusted by mission-critical organizations in healthcare and distribution to build
resilient, efficient and secure supply chains. A global provider of cloud-based, AI-driven
software with deep domain expertise, Tecsys delivers real-time operational visibility and
execution across critical workflows when performance and reliability matter
most. Tecsys is publicly traded on the Toronto Stock Exchange (TSX: TCS). For more
information, visit www.tecsys.com.

Contact

• Public Relations: Shannon Karl, shannon.karl@tecsys.com

• General Information: info@tecsys.com

• Investor Relations: investors@tecsys.com

• By Phone: (514) 866-0001 or (800) 922-8649

Forward Looking Statements

The statements in this news release relating to matters that are not historical fact are
forward-looking statements that are based on management’s beliefs and assumptions.
Such statements are not guarantees of future performance and are subject to a number
of uncertainties, including but not limited to future economic conditions, the markets
that Tecsys Inc. serves, the actions of competitors, major new technological trends, and
other factors beyond the control of Tecsys Inc., which could cause actual results to differ
materially from such statements. More information about the risks and uncertainties
associated with Tecsys Inc.’s business can be found in the MD&A section of the
Company’s annual report and the most recently filed annual information form. These
documents have been filed with the Canadian securities commissions and are available
on our website (www.tecsys.com) and on SEDAR+ (www.sedarplus.ca).

Copyright © Tecsys Inc. 2026. All names, trademarks, products, and services mentioned
are registered or unregistered trademarks of their respective owners.